A compartmental model for biokinetics and dosimetry of 18F- choline in prostate cancer patients

Journal of Nuclear Medicine

Volumn 53, Issue 6, 2012, Pages 985-993

  Giussani, Augusto ^a   Janzen, Tilman ^a   Uusijärvi Lizana, Helena ^b   Tavola, Federico ^c   Zankl, Maria ^a   Sydoff, Marie ^b   Bjartell, Anders ^d   Leide Svegborn, Sigrid ^b   Söderberg, Marcus ^b   Mattsson, Sören ^b   Hoeschen, Christoph ^a   Cantone, Marie Claire ^c  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b LUND UNIVERSITY   (Sweden)

^c UNIVERSITY OF MILAN   (Italy)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

18F choline; Biokinetics; Dosimetry; PET; Prostate carcinoma

Indexed keywords

CHOLINE F 18; TRACER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLADDER WALL; BLOOD VOLUME; CLINICAL ARTICLE; COMPARTMENT MODEL; DOSIMETRY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG URINE LEVEL; HUMAN; KIDNEY; LIVER; MALE; MICTURITION; PHANTOM; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; SWEDEN;

AGED; CHOLINE; FLUORINE RADIOISOTOPES; HUMANS; KINETICS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; PROSTATIC NEOPLASMS; RADIOMETRY; TISSUE DISTRIBUTION; URINARY BLADDER;

EID: 84861876807     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.111.099408     Document Type: Article

References (29)

1. Ackerstaff E, Glunde K, Bhujwalla Z. Choline phospholipid metabolism: a target in cancer cells? J Cell Biochem. 2003;90:525-533. (Pubitemid 37243700)
2. Ramírez de Molina A, Rodriguez-Gonzalez A, Gutierrez R, Martinez-Pineiro L, Sanchez J, Bonilla F. Overexpression of choline kinase is a frequent feature in human tumor-derived cell lines and in lung, prostate, and colorectal human cancers. Biochem Biophys Res Commun. 2002;296:580-583.
3. 18F-fluorocholine PET. J Nucl Med. 2006;47:262-269.
4. DeGrado TR, Reiman RE, Price DT, Shuyan W, Coleman RE. Pharmacokinetics and radiation dosimetry of 18F-fluorocholine. J Nucl Med. 2002;43:92-96.
5. 11C] choline uptake in prostate cancer: a PET study. Eur J Nucl Med Mol Imaging. 2004;31:317-324.
6. Schmid DT, John H, Zweifel R, et al. Fluorocholine PET/CT in patients with prostate cancer: initial experience. Radiology. 2005;235:623-628. (Pubitemid 40571106)
7. 18F- fluorocholine PET/CT in the evaluation of prostate cancer recurrence. Nuklearmedizin. 2009;48:1-9.
8. 18F-choline studied in four prostate cancer patients. Radiat Prot Dosimetry. 2010;139:240-244.
9. Hoeschen C, Mattsson S, Cantone MC, et al. Minimising activity and dose with enhanced image quality by radiopharmaceutical administrations. Radiat Prot Dosimetry. 2010;139:250-253.
10. 11C] choline; implications for in vivo imaging with positron emission tomography. Eur J Nucl Med. 2000;27:25-32.
11. 18F-choline. Nucl Med Biol. 2012;39:261-268.
12. 18F-choline. In: Molthen RC, Weaver JB, eds. Medical Imaging 2010: Biomedical Applications in Molecular, Structural, and Functional Imaging. Bellingham, WA: SPIE; 2010.
13. Barrett PHR, Bell BM, Cobelli C, Golde H, Schumitzky A, Vicini P. SAAM II: simulation, analysis, and modeling software for tracer and pharmacokinetic studies. Metabolism. 1998;47:484-492. (Pubitemid 28180958)
14. D'Argenio DZ, Schumitzky A, Wang X. ADAPT 5 User's Guide: Pharmacokinetic/Pharmacodynamic Systems Analysis Software. Los Angeles, California: Biomedical Simulations Resource; 2009.
15. Dempster AP, Laird NM, Rubin DB. Maximum likelihood from incomplete data via the EM algorithm. J R Stat Soc, B. 1977;39:1-38.
16. Walker S. An EM algorithm for nonlinear random effects models. Biometrics. 1996;52:934-944. (Pubitemid 26296070)
17. Audoly S, D'Angio L, Saccomanni MP, Cobelli C. Global identifiability of linear compartment models: a computer algebra algorithm. IEEE Trans Biomed Eng. 1998;45:36-47. (Pubitemid 28053011)
18. Bolch WE, Eckerman KF, Sgouros G, Thomas SR. MIRD pamphlet no. 21: a generalised schema for radiopharmaceutical dosimetry: standardization of nomenclature. J Nucl Med. 2009;50:477-484.
19. International Commission on Radiological Protection (ICRP). ICRP publication 110: adult reference computational phantoms. Ann ICRP. 2009;39.
20. Petoussi-Henss N, Zankl M, Fill U, Regulla D. The GSF family of voxel phantoms. Phys Med Biol. 2002;47:89-106. (Pubitemid 34081083)
21. Kawrakow I, Rogers DWO. The EGSnrc Code System: Monte Carlo Simulation of Electron and Photon Transport. PIRS report 701, 4th ed. Ottawa, Canada: National Research Council of Canada; 2003.
22. International Commission on Radiological Protection (ICRP). ICRP publication 107: nuclear decay data for dosimetric calculations. Ann ICRP. 2008;38.
23. International Commission on Radiological Protection (ICRP). ICRP publication 60: 1990 recommendations of the International Commission on Radiological Protection. Ann ICRP. 1991;21.
24. Foster DM. Developing and testing integrated multicompartment models to describe a single-input multiple-output study using the SAAM II software system. In: Clifford AJ, Müller H-G, eds. Mathematical Modeling in Experimental Nutrition. New York, NY: Plenum Press; 1998: 59-78. (Pubitemid 28391766)
25. Stabin MG, Sparks RB, Crowe E. OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine. J Nucl Med. 2005;46:1023-1027. (Pubitemid 43733519)
26. Cristy M, Eckerman KF. Specific Absorbed Fractions of Energy at Various Ages from Internal Photon Sources. I. Methods. Report ORNL/TM-8381/V1. Oak Ridge, TN: Oak Ridge National Laboratory; 1987.
27. Stabin MG, Kroijnenberg M. Re-evaluation of absorbed fractions for photons and electrons in small spheres. J Nucl Med. 2000;41:149-160. (Pubitemid 30046697)
28. Noßke D, Brix G. Dose assessment for C-11 and F-18-choline [abstract]. J Nucl Med. 2009;50(suppl 2):1851P.
29. International Commission on Radiological Protection (ICRP). ICRP publication 103: the 2007 recommendations of the International Commission on Radiological Protection. Ann ICRP. 2007;37.